Cyanocobalamin

+ 34 more variants

• Nausea and Vomiting: More common with high-dose oral tablets taken on an empty stomach.
• Joint Pain (Arthralgia): Some patients report temporary aches in the joints following an injection.
• Anxiety or Nervousness: A 'jittery' feeling can occur, possibly due to the rapid metabolic changes initiated by the vitamin.
• Nasopharyngitis: Specifically associated with the nasal spray formulation, causing irritation in the throat or nose.

• Hypokalemia (Low Potassium): This is a critical but rare side effect that occurs during the initial treatment of severe megaloblastic anemia. As B12 triggers the rapid production of new red blood cells, the body consumes large amounts of potassium, leading to a drop in serum potassium levels. This can cause cardiac arrhythmias or muscle weakness.
• Polycythemia Vera: In rare cases, B12 therapy can unmask polycythemia vera (a blood cancer where the bone marrow makes too many red blood cells).
• Secondary Thrombocytosis: A temporary increase in platelet count as the bone marrow recovers.

> Warning: Stop taking Cyanocobalamin and call your doctor immediately if you experience any of these symptoms. These may indicate a severe allergic reaction or cardiovascular complication.

• Anaphylaxis: Signs include hives, difficulty breathing, swelling of the face, lips, or tongue, and a rapid heartbeat. This is more common with the injectable form.
• Pulmonary Edema: Shortness of breath, wheezing, or gasping for air, especially when lying down.
• Congestive Heart Failure: Rapid weight gain, swelling in the ankles or legs (edema), and extreme fatigue.
• Peripheral Vascular Thrombosis: Pain, warmth, or redness in a single leg, which could indicate a blood clot.
• Vision Changes: Sudden blurring or loss of vision, which is particularly concerning in patients with Leber's disease.

Long-term use of cyanocobalamin is generally considered safe. However, some studies have suggested that extremely high, prolonged serum levels of B12 (hypervitaminosis B12) might be associated with an increased risk of acne or rosacea outbreaks. There is also ongoing research into the relationship between very high B12 levels and lung cancer risk in smokers, though a causal link has not been definitively established. For most patients, the benefits of preventing permanent neurological damage far outweigh these theoretical risks.

No FDA black box warnings exist for Cyanocobalamin. It is considered one of the safest pharmacological agents when used as directed. However, the lack of a black box warning does not mean the drug is without risk, particularly for those with underlying cobalt allergies or Leber’s hereditary optic atrophy.

Report any unusual symptoms to your healthcare provider. If you believe you are having a medical emergency, dial 911 or your local emergency services immediately.

To ensure safety and efficacy, the following monitoring is typically required:

• Serum B12 Levels: Checked before treatment and periodically (e.g., every 3 to 6 months) during maintenance.
• Complete Blood Count (CBC): To monitor hemoglobin, hematocrit, and mean corpuscular volume (MCV). Reticulocyte counts (young red blood cells) should rise within 3-10 days of starting therapy.
• Potassium Levels: Specifically during the first week of treatment for severe anemia.
• Folate and Iron Levels: Deficiency in these nutrients can prevent a full response to B12 therapy; they must be monitored and supplemented if necessary.

Cyanocobalamin generally does not impair the ability to drive or operate machinery. However, if a patient is suffering from severe anemia-related fatigue or neurological symptoms like dizziness, they should exercise caution until these symptoms improve with treatment.

Chronic, excessive alcohol consumption can interfere with the absorption of Vitamin B12 by damaging the stomach lining and reducing the production of Intrinsic Factor. While an occasional drink is unlikely to cause a direct drug interaction, patients being treated for B12 deficiency should limit alcohol intake to ensure maximum absorption of the medication.

For patients with pernicious anemia or permanent malabsorption (such as after a total gastrectomy), cyanocobalamin therapy is lifelong. Discontinuing the medication will eventually lead to the depletion of liver stores, resulting in a recurrence of anemia and potentially irreversible nerve damage. Never stop taking this medication without consulting your doctor.

> Important: Discuss all your medical conditions, including any history of gout, kidney disease, or eye problems, with your healthcare provider before starting Cyanocobalamin.

• H2-Receptor Antagonists: Similar to PPIs, drugs like famotidine and cimetidine reduce gastric acid and can lower the absorption of dietary B12 over time.
• Colchicine: This gout medication can cause generalized malabsorption in the small intestine, potentially reducing the uptake of B12.
• Aminosalicylic Acid: Used for tuberculosis or inflammatory bowel disease, this drug can reduce B12 absorption by up to 50%.

• Vitamin C (Ascorbic Acid): Some studies suggest that taking high doses of Vitamin C (500 mg or more) within an hour of taking oral B12 can destroy the vitamin in the gastrointestinal tract. To avoid this, it is recommended to take Vitamin C at least 2 hours after taking cyanocobalamin.
• Alcohol: As mentioned, chronic alcohol use impairs the body's ability to absorb B12 and can deplete liver stores.

• Folic Acid: While not a negative interaction in terms of absorption, high doses of folic acid can 'mask' a B12 deficiency by fixing the anemia while the nerve damage continues. Patients should not take high-dose folate without ensuring their B12 levels are adequate.
• Potassium Supplements: Extended-release potassium supplements can sometimes interfere with B12 absorption in the ileum.

Cyanocobalamin can interfere with certain laboratory tests. High levels of B12 in the blood can cause false results in assays for other vitamins or certain antibodies. If you are undergoing a blood test, always inform the laboratory that you are taking B12 supplements, especially if the test involves competitive binding assays.

For each major interaction, the management strategy usually involves either separating the doses by several hours or increasing the frequency of B12 monitoring. In the case of Metformin or PPIs, your doctor may recommend switching to an injectable form of B12 to bypass the digestive tract entirely.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter vitamins.

Patients who are allergic to Hydroxocobalamin or Methylcobalamin are likely to be allergic to Cyanocobalamin as well, as they all share the same corrin ring structure. Cross-sensitivity to other cobalt-containing compounds (like certain industrial dyes or metal alloys) is also possible.

> Important: Your healthcare provider will evaluate your complete medical history, including any rare genetic disorders, before prescribing Cyanocobalamin.

Cyanocobalamin is approved for use in children for the treatment of deficiency and certain metabolic disorders.

• Cautions: As noted previously, the use of parenteral (injectable) B12 containing benzyl alcohol must be avoided in neonates and infants due to the risk of 'gasping syndrome,' a fatal condition characterized by metabolic acidosis and respiratory distress.
• Dosing: Pediatric dosing is strictly weight-based and must be managed by a specialist.

Patients over the age of 65 are at the highest risk for B12 deficiency, often due to atrophic gastritis or the use of medications like Metformin and PPIs.

• Cognitive Impact: B12 deficiency in the elderly can mimic dementia or Alzheimer's disease. Correction of the deficiency can sometimes improve cognitive function, though it cannot reverse established dementia.
• Absorption: Geriatric patients should generally receive B12 via injection or high-dose sublingual tablets to ensure adequate levels, as intestinal absorption is often compromised.

In patients with kidney disease, the excretion of B12 and its metabolites may be slowed. While B12 itself is non-toxic, the accumulation of the cyanide ligand in cyanocobalamin is a theoretical concern in ESRD. Some specialists prefer using hydroxocobalamin in these patients, as it can actually help scavenge cyanide.

No specific dose adjustments are required. However, clinicians should be aware that liver disease can cause falsely elevated serum B12 levels because the damaged liver cells 'leak' the stored vitamin into the bloodstream, even if the body's total stores are low.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or nursing.

The pharmacodynamic effect of cyanocobalamin is observed through the normalization of blood counts and the reduction of serum MMA and homocysteine levels.

• Onset: Reticulocytosis (increase in young red blood cells) typically begins within 3 to 5 days of starting therapy.
• Peak Effect: Hemoglobin and hematocrit levels usually begin to rise within 7 to 10 days and should reach normal levels within 4 to 8 weeks.
• Neurological Recovery: Nerve-related symptoms may take several months to improve, and in cases of long-standing deficiency, some damage may be permanent.

| Parameter | Value |

|---|---|

| Bioavailability | 1-5% (Oral, dose-dependent); 100% (IM) |

| Protein Binding | >90% (to Transcobalamins) |

| Half-life | ~6 days (Biological); Years (Liver stores) |

| Tmax | 8-12 hours (Oral); 1 hour (IM) |

| Metabolism | Intracellular conversion to active coenzymes |

| Excretion | Renal (excess); Biliary (enterohepatic cycling) |

• Molecular Formula: C63H88CoN14O14P
• Molecular Weight: 1355.37 g/mol
• Solubility: Sparingly soluble in water (1 in 80); soluble in alcohol.
• Structure: A central cobalt atom coordinated to a corrin ring, a nucleotide (dimethylbenzimidazole), and a cyanide group.

Cyanocobalamin is classified as a Water-Soluble Vitamin (Vitamin B12 Analog). It is related to other cobalamins like hydroxocobalamin (often used for cyanide poisoning) and methylcobalamin (a naturally occurring form).